Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) is a dynamic trade association that

represents a unique sector of the biologics and biotechnology industry. PPTA represents

more than 1,000 human plasma collection centers in North America and Europe, as well as

the manufacturers of lifesaving plasma protein therapies. Our members produce

approximately 80% of the plasma protein therapies in the U.S. and 60% of those manufactured in Europe.

PPTA also administers standards and programs that help ensure the quality and safety of

plasma collection and manufacturing and protect both donors and patients.



The International Plasma and Fractionation Association (IPFA)

IPFA is the association for not-for-profit plasma organizations.

IPFA is The International Plasma and Fractionation Association.

(IPFA) is an association representing organizations engaged in the collection of plasma

and fractionation of it into plasma-derived medicinal products.

IPFA´s members are from the not-for-profit sector and come from all over the world. They

represent both blood establishments collecting plasma and manufacturers (fractionators)

who produce plasma-derived products.  

IPFA´s aim is to enable robust, safe supply and patient access to life-saving plasma-

derived medicines while strengthening the contribution and ability of the public sector to

collect plasma within their communities for this purpose.

 We encourage and help the not-for-profit blood establishment to increase their collection

of plasma for fractionation and their aims to conduct this task alongside the collection of

other blood components, with a strong emphasis on donations without financial gain,

donor health protection, and long-term commitment.  

Plasma is a strategic resource for plasma-derived medicines, needed all over the world. By

focusing on the local and regional collection of plasma and its use to produce medicines

for the same community, the combined efforts become an integral part of a public health

system and bring health value to patients. This way countries and regions can reach a

better level of strategic independence for both plasma and plasma-derived medicines,

which is both sustainable and plays a key role in contingency planning



CSL is a leading global biotechnology company

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving

medicines, including those that treat hemophilia and immune deficiencies, as well as

vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise

to save lives using the latest technologies. Today, CSL – including our three businesses,

CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in

more than 100 countries and employs 30,000 people.





Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma



 is a leading Chinese biopharmaceutical



Recognising the importance of plasma and with over 60 years of experience in the industry, BPL supplies high-quality plasma-derived 



JB is a general incorporated association formed by the integration of the plasma fractionation operation 





Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. 



With advanced research, we create innovative vaccines and bio-therapeutics for a healthier tomorrow.